Mari Hirvinen
- Genetics top 5%
- Oncology top 5%
- Molecular Biology
- Immunology top 10%
- Biotechnology top 5%
- Co-authors
- Vincenzo CerulloAkseli HemminkiIulia DiaconuAnna KanervaSaila K. PesonenCristian CapassoSophie EscutenaireMariangela Garofalo
- Topics
- Virus-based gene therapy research (17 papers)CAR-T cell therapy research (11 papers)Cancer Research and Treatments (5 papers)
- Cited by
- GeneticsBiotechnologyOncology
In The Last Decade
Mari Hirvinen
19 papers receiving 867 citations
Peers
Comparison fields: 5 of 49
- Genetics 651
- Oncology 550
- Molecular Biology 361
- Immunology 236
- Biotechnology 196
Countries citing papers authored by Mari Hirvinen
This map shows the geographic impact of Mari Hirvinen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mari Hirvinen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mari Hirvinen more than expected).
Fields of papers citing papers by Mari Hirvinen
This network shows the impact of papers produced by Mari Hirvinen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mari Hirvinen. The network helps show where Mari Hirvinen may publish in the future.
Co-authorship network of co-authors of Mari Hirvinen
This figure shows the co-authorship network connecting the top 25 collaborators of Mari Hirvinen. A scholar is included among the top collaborators of Mari Hirvinen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mari Hirvinen. Mari Hirvinen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 41 | |
| 2 | 34 | |
| 3 | 3 | |
| 4 | 45 | |
| 5 | 47 | |
| 6 | 68 | |
| 7 | 1 | |
| 8 | 1 | |
| 9 | 9 | |
| 10 | 35 | |
| 11 | 50 | |
| 12 | 15 | |
| 13 | 139 | |
| 14 | 34 | |
| 15 | 9 | |
| 16 | 2 | |
| 17 | 136 | |
| 18 | 81 | |
| 19 | 128 |
About Mari Hirvinen
Mari Hirvinen is a scholar working on Genetics, Biotechnology and Oncology, having authored 19 papers that have together received 878 indexed citations. Recurring topics across this work include Virus-based gene therapy research (17 papers), CAR-T cell therapy research (11 papers) and Cancer Research and Treatments (5 papers). The work is most often cited by research in Genetics (651 citations), Biotechnology (196 citations) and Oncology (550 citations). Mari Hirvinen has collaborated with scholars based in Finland, Italy and Sweden. Frequent co-authors include Vincenzo Cerullo, Akseli Hemminki, Iulia Diaconu, Anna Kanerva, Saila K. Pesonen, Cristian Capasso, Sophie Escutenaire, Mariangela Garofalo, Suvi Parviainen and Simona Bramante. Their work appears in journals such as Cancer Research, International Journal of Cancer and Molecular Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.